Litcius/Paper detail

IL-15 immunotherapy is a viable strategy for COVID-19

Hemanth Kumar Kandikattu, Sathisha Upparahalli Venkateshaiah, Sandeep Kumar, Anil Mishra

2020Cytokine & Growth Factor Reviews54 citationsDOIOpen Access PDF

Topics & Concepts

Cytokine stormImmunologyCoronavirusImmune systemImmunotherapyMedicineVirologyAcquired immune systemCytokineCytokine release syndromeDiseaseCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)Chimeric antigen receptorPathologyImmune Cell Function and InteractionCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research
IL-15 immunotherapy is a viable strategy for COVID-19 | Litcius